RNA COVID-19 vaccines — originally developed to protect against the coronavirus — may be providing an additional, unexpected health advantage.

Researchers found that among cancer patients getting immunotherapy, those who got an mRNA Covid vaccine within 100 days ...

Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy ...

An analysis of patient records suggests that mRNA covid-19 vaccines boost the immune response to cancerous tumours when given ...

Most vaccines contain an infectious pathogen or a part of it, but mRNA vaccines deliver the genetic instructions for our cells to make viral or bacterial proteins themselves. Our immune system ...

A team led by Neil King, a biochemistry professor at the University of Washington School of Medicine, is now exploring a new approach to COVID vaccines: using mRNA to let the body assemble its own ...

Messenger RNA, or mRNA, vaccines work by instructing a small number of a person’s cells to make specific proteins. In the case of the approved mRNA vaccines for COVID-19, the cells make spike protein ...

In the fast-evolving field of medical science, a new artificial intelligence model may be about to change the way mRNA-based drugs and vaccines are designed. Developed through a collaboration between ...

A new study suggests that these vaccines might boost the effects of immunotherapy drugs, perhaps by alerting the immune ...

Katalin Karikó and Dr. Drew Weissman, American scientists whose long collaboration has revolutionized the making of vaccines and raised the prospect of new treatments for a range of afflictions, were ...

An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice ...

Dr. Drew Weissman, left, a physician-scientist, and biochemist Katalin Karikó won the Nobel Prize in medicine for discoveries that enabled the creation of mRNA vaccines against COVID-19 and that could ...